Literature DB >> 11926820

Anisotropic dynamics of the JE-2147-HIV protease complex: drug resistance and thermodynamic binding mode examined in a 1.09 A structure.

K Kinkead Reiling1, Nicholas F Endres, Deborah S Dauber, Charles S Craik, Robert M Stroud.   

Abstract

The structure of HIV protease (HIV Pr) bound to JE-2147 (also named AG1776 or KNI-764) is determined here to 1.09 A resolution. This highest-resolution structure for HIV Pr allows refinement of anisotropic displacement parameters (ADPs) for all atoms. Clustering based on the directional information in ADPs defines two sets of subdomains such that within each set, subdomains undergo similar anisotropic motion. These sets are (a) the core of monomer A grouped with both substrate-binding flaps and (b) the core of monomer B coupled to both catalytic aspartates (25A/B). The four-stranded beta-sheet (1-4 A/B and 95-99 A/B) that forms a significant part of the dimer interface exhibits large anisotropic amplitudes that differ from those of the other sets of subdomains. JE-2147 is shown here to be a picomolar inhibitor (K(i) = 41 +/- 18 pM). The structure is used to interpret the mechanism of association of JE-2147, a second-generation inhibitor for which binding is enthalpically driven, with respect to first-generation inhibitors for which binding is predominantly entropically driven [Velazquez-Campoy, A., et al. (2001) Arch. Biochem. Biophys. 390, 169-175]. Relative to the entropically driven inhibitor complexes, the JE-2147-HIV Pr complex exhibits an approximately 0.5 A movement of the substrate flaps in toward the substrate, suggesting a more compatible enthalpically driven association. Domains of the protease identified by clustering of ADPs also suggest a model of enthalpy-entropy compensation for all HIV Pr inhibitors in which dynamic coupling of the flaps is offset by an increased level of motion of the beta-sheet domain of the dimer interface (1-4 A/B and 95-99 A/B).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926820     DOI: 10.1021/bi011781z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Potent antiviral HIV-1 protease inhibitor GRL-02031 adapts to the structures of drug resistant mutants with its P1'-pyrrolidinone ring.

Authors:  Yu-Chung E Chang; XiaXia Yu; Ying Zhang; Yunfeng Tie; Yuan-Fang Wang; Sofiya Yashchuk; Arun K Ghosh; Robert W Harrison; Irene T Weber
Journal:  J Med Chem       Date:  2012-03-22       Impact factor: 7.446

2.  Gaussian-weighted RMSD superposition of proteins: a structural comparison for flexible proteins and predicted protein structures.

Authors:  Kelly L Damm; Heather A Carlson
Journal:  Biophys J       Date:  2006-03-24       Impact factor: 4.033

3.  Potent new antiviral compound shows similar inhibition and structural interactions with drug resistant mutants and wild type HIV-1 protease.

Authors:  Yuan-Fang Wang; Yunfeng Tie; Peter I Boross; Jozsef Tozser; Arun K Ghosh; Robert W Harrison; Irene T Weber
Journal:  J Med Chem       Date:  2007-08-16       Impact factor: 7.446

4.  Temperature dependence of fluctuations in HIV1-protease.

Authors:  Kay Hamacher
Journal:  Eur Biophys J       Date:  2009-03-27       Impact factor: 1.733

5.  Ligand-Binding-Site Structure Refinement Using Molecular Dynamics with Restraints Derived from Predicted Binding Site Templates.

Authors:  Hugo Guterres; Hui Sun Lee; Wonpil Im
Journal:  J Chem Theory Comput       Date:  2019-10-14       Impact factor: 6.006

6.  Fragment-based screen against HIV protease.

Authors:  Alexander L Perryman; Qing Zhang; Holly H Soutter; Robin Rosenfeld; Duncan E McRee; Arthur J Olson; John E Elder; C David Stout
Journal:  Chem Biol Drug Des       Date:  2010-01-19       Impact factor: 2.817

7.  Modeling Protein-Ligand Binding by Mining Minima.

Authors:  Wei Chen; Michael K Gilson; Simon P Webb; Michael J Potter
Journal:  J Chem Theory Comput       Date:  2010-10-08       Impact factor: 6.006

8.  HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs.

Authors:  Alexander L Perryman; Jung-Hsin Lin; J Andrew McCammon
Journal:  Protein Sci       Date:  2004-04       Impact factor: 6.725

9.  Combining Molecular Dynamic Information and an Aspherical-Atom Data Bank in the Evaluation of the Electrostatic Interaction Energy in Multimeric Protein-Ligand Complex: A Case Study for HIV-1 Protease.

Authors:  Prashant Kumar; Paulina Maria Dominiak
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

10.  Modelling dynamics in protein crystal structures by ensemble refinement.

Authors:  B Tom Burnley; Pavel V Afonine; Paul D Adams; Piet Gros
Journal:  Elife       Date:  2012-12-18       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.